• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INGEVITY+; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INGEVITY+; IMPLANTABLE LEAD Back to Search Results
Model Number 7841
Device Problems Failure to Capture (1081); Failure to Read Input Signal (1581); Device Dislodged or Dislocated (2923); High Capture Threshold (3266); Migration (4003)
Patient Problem Perforation (2001)
Event Date 02/16/2024
Event Type  Injury  
Event Description
It was reported that this patient was implanted with a pacemaker system.One day post operative, the field representative went to perform a pre-discharge check and noted right atrial (ra) and right ventricular (rv) thresholds were higher than at implant.Impedance and amplitudes were within range.The device was programmed to unipolar, and thresholds were checked again and this time there was loss of capture on both leads.A chest x-ray was performed and there was suspected lead migration/dislodgement and perforation for both leads.The physician decided to perform a lead extraction and use passive fixed leads.A lead revision procedure was performed, and the leads were removed.When they connected the new leads to the device there was a drop in r wave amplitudes therefore, the rv lead was re-positioned.This time they had good measurements from the pacing system analyzer (psa) and from the device, so they began closing the pocket.On the sub-q layer of sutures, there was an increase instance of failed av search so lead tests were ran again.It was noted there was an acute rise in rv thresholds in bipolar and again loss of capture in unipolar.The device was removed from the pocket, and they tested ra and rv thresholds using the psa and they were acceptable measurements.The leads were plugged back in the original device used from implant and there were normal measurements in bipolar however, abnormal measurements when in unipolar.The ra had loss of capture and rv had high thresholds.Subsequently, the device was removed, and a new device was implanted.Lead testing was performed, and all lead measurements were within range.At pre-discharge they confirmed again all measurements were normal when programmed in bipolar and unipolar.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INGEVITY+
Type of Device
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key18808715
MDR Text Key336574252
Report Number2124215-2024-12273
Device Sequence Number1
Product Code NVN
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 02/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/29/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number7841
Device Catalogue Number7841
Device Lot Number1397929
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/17/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/26/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age87 YR
Patient SexFemale
-
-